Friday, July 7, 2023

FDA delaying investigation, accountability over baby formula shortage

 U.S. House oversight lawmakers reviewing the FDA's role in the baby formula shortage say the federal agency is dodging oversight and delaying providing answers.

McClain argues the FDA has delayed the investigation significantly.

"The more the Oversight Committee uncovers in our investigation into internal failures at the FDA which led our nation into an infant formula crisis, the more questions we have for the FDA," the letter said.

McClain's Subcommittee on Health Care and Financial Services laid out several FDA failings, saying the "The FDA's dysfunction and delay worsened the formula crisis" and that the agency "Has failed to conduct an independent, objective review of the crisis." "Affiliated parties at the FDA have still not been held accountable," the committee added.

Many lawmakers blasted the FDA for its role in the crisis.

In May of last year, U.S. Sen. Tom Cotton, R-Ark., called it a "National crisis hitting poor moms and kids the hardest." The FDA took fire for its long list of baby formula regulations and how it forced a recall of European formula over labeling issues.

"The FDA needs to immediately step up, be transparent, explain how it will get production restarted, and give parents a timeline," he added. 

https://www.thecentersquare.com/national/article_d1c20bf6-1bfe-11ee-af04-f3a80aa618e7.html

No comments:

Post a Comment